The End of “One Size Fits All”: Personalized Treatment of Breast Cancer
Giving every breast cancer patient the exact same chemotherapy is archaic and deadly. Two tumors that look identical under a microscope can have completely different genetic engines driving them; one will melt away with a simple pill, the other will violently resist everything except maximum-dose IV poison. Personalized Treatment of Breast Cancer is a fiercely advanced, brilliantly complex molecular oncology manual detailing exactly how to exploit these genetic differences. This volume provides the precise biological blueprints required to guarantee that every single patient receives a weapon mathematically matched to their tumor.
Mastering the Genomic Profile
The core philosophy of this text is molecular interrogation. The authors aggressively detail the mechanics of the multigene assay. It dictates exactly how tests like MammaPrint and Oncotype DX extract the RNA from the tumor tissue to analyze the expression of dozens of specific genes simultaneously, generating a definitive numerical score that legally and medically dictates whether the patient can safely avoid chemotherapy.
Navigating the PI3K/AKT/mTOR Pathway
The book provides a masterclass in overcoming acquired resistance. It dictates the exact pharmacological pathways for targeted blockade. It rigorously explores how an estrogen-positive tumor eventually mutates to become completely immune to hormone-blocking drugs, and how oncologists must instantly pivot to prescribe targeted mTOR inhibitors (like Everolimus) to violently shut down this specific escape route.
Frequently Asked Questions (FAQs)
Is this a surgical manual for performing radical mastectomies?
No, its absolute, exclusive focus is on the *medical oncology, targeted pharmacology, and molecular genetics* required to customize systemic drug therapy.
Who is the primary audience?
It is the absolute, mandatory definitive reference for Medical Oncologists, Molecular Pathologists, Breast Surgeons, and Translational Researchers.
